Fulcrum Therapeutics Inc (FULC)
3.77
-0.23
(-5.75%)
USD |
NASDAQ |
Sep 27, 16:00
3.84
+0.07
(+1.86%)
After-Hours: 20:00
Fulcrum Therapeutics Cash and Short Term Investments (Quarterly): 273.78M for June 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 273.78M |
| March 31, 2024 | 213.31M |
| December 31, 2023 | 236.22M |
| September 30, 2023 | 257.09M |
| June 30, 2023 | 278.16M |
| March 31, 2023 | 297.84M |
| December 31, 2022 | 202.92M |
| September 30, 2022 | 221.79M |
| June 30, 2022 | 168.97M |
| March 31, 2022 | 195.11M |
| December 31, 2021 | 218.16M |
| September 30, 2021 | 240.34M |
| Date | Value |
|---|---|
| June 30, 2021 | 125.55M |
| March 31, 2021 | 143.86M |
| December 31, 2020 | 112.91M |
| September 30, 2020 | 127.02M |
| June 30, 2020 | 131.74M |
| March 31, 2020 | 81.21M |
| December 31, 2019 | 96.71M |
| September 30, 2019 | 101.60M |
| June 30, 2019 | 49.63M |
| March 31, 2019 | 62.45M |
| December 31, 2018 | 72.80M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
81.21M
Minimum
Mar 2020
297.84M
Maximum
Mar 2023
186.22M
Average
199.02M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Bioventus Inc | 31.99M |
| Arcturus Therapeutics Holdings Inc | 260.33M |
| Entrada Therapeutics Inc | 469.75M |
| Johnson & Johnson | 25.48B |
| Insmed Inc | 1.247B |